# Animal-Assisted Visitation Program Chlorhexidine Trial

> **NCT04171817** · PHASE4 · COMPLETED · sponsor: **Johns Hopkins Bloomberg School of Public Health** · enrollment: 45 (actual)

## Conditions studied

- Methicillin-resistant Staphylococcus Aureus
- Clostridium Difficile
- Pseudomonas Aeruginosa

## Interventions

- **DRUG:** Chlorhexidine

## Key facts

- **NCT ID:** NCT04171817
- **Lead sponsor:** Johns Hopkins Bloomberg School of Public Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-01
- **Primary completion:** 2025-09-01
- **Final completion:** 2026-04-01
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04171817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04171817, "Animal-Assisted Visitation Program Chlorhexidine Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04171817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*